Purchases and Sales Made in Q3 2023 in Supernus Pharmaceuticals, Inc. (SUPN)
This table provides information about the institutional ownership of Supernus Pharmaceuticals, Inc. (SUPN) during Q3 2023. The information is specifically focused on institutions that hold shares of SUPERNUS PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 08, 2023
Q3 2023
|
Burney CO
Reston, VA |
SELL
|
- |
-115K- 61.52% |
$3.16M - $3.77M
|
71.7K
$2.72M
|
|
|
Nov 09, 2023
Q3 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-116K- 4.78% |
$3.2M - $3.82M
|
2.31M
$87.8M
|
|
|
Nov 14, 2023
Q3 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-190K- 73.94% |
$5.24M - $6.26M
|
67K
$2.54M
|
|
|
Nov 13, 2023
Q3 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-429KClosed |
$11.8M - $14.1M
|
0
$0
|
|
|
Nov 13, 2023
Q3 2023
|
Pacer Advisors, Inc.
Malvern, PA |
SELL
|
- |
-449K- 99.93% |
$12.4M - $14.8M
|
303
$11.5K
|